Cargando…

CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?

Chemical leukoderma denotes an acquired hypopigmentation caused by repeated exposure to specific chemical compounds simulating clinically idiopathic vitiligo. The ailment has been increasing in developing countries like India in recent years. Etiologically, a lot of chemicals, especially phenolic gr...

Descripción completa

Detalles Bibliográficos
Autor principal: Ghosh, Sanjay
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965912/
https://www.ncbi.nlm.nih.gov/pubmed/21063518
http://dx.doi.org/10.4103/0019-5154.70680
_version_ 1782189557842706432
author Ghosh, Sanjay
author_facet Ghosh, Sanjay
author_sort Ghosh, Sanjay
collection PubMed
description Chemical leukoderma denotes an acquired hypopigmentation caused by repeated exposure to specific chemical compounds simulating clinically idiopathic vitiligo. The ailment has been increasing in developing countries like India in recent years. Etiologically, a lot of chemicals, especially phenolic group, have been identified in various countries including India. The term, “chemical leukoderma syndrome” has been described to encompass all the various manifestations of chemical leukoderma. Clinical diagnostic criteria have been proposed to diagnose chemical leukoderma clinically more confidently.
format Text
id pubmed-2965912
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-29659122010-11-09 CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS? Ghosh, Sanjay Indian J Dermatol IJD Symposium Chemical leukoderma denotes an acquired hypopigmentation caused by repeated exposure to specific chemical compounds simulating clinically idiopathic vitiligo. The ailment has been increasing in developing countries like India in recent years. Etiologically, a lot of chemicals, especially phenolic group, have been identified in various countries including India. The term, “chemical leukoderma syndrome” has been described to encompass all the various manifestations of chemical leukoderma. Clinical diagnostic criteria have been proposed to diagnose chemical leukoderma clinically more confidently. Medknow Publications 2010 /pmc/articles/PMC2965912/ /pubmed/21063518 http://dx.doi.org/10.4103/0019-5154.70680 Text en © Indian Journal of Dermatology http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle IJD Symposium
Ghosh, Sanjay
CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?
title CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?
title_full CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?
title_fullStr CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?
title_full_unstemmed CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?
title_short CHEMICAL LEUKODERMA: WHAT’S NEW ON ETIOPATHOLOGICAL AND CLINICAL ASPECTS?
title_sort chemical leukoderma: what’s new on etiopathological and clinical aspects?
topic IJD Symposium
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965912/
https://www.ncbi.nlm.nih.gov/pubmed/21063518
http://dx.doi.org/10.4103/0019-5154.70680
work_keys_str_mv AT ghoshsanjay chemicalleukodermawhatsnewonetiopathologicalandclinicalaspects